SE0102385D0 - Screening methods - Google Patents

Screening methods

Info

Publication number
SE0102385D0
SE0102385D0 SE0102385A SE0102385A SE0102385D0 SE 0102385 D0 SE0102385 D0 SE 0102385D0 SE 0102385 A SE0102385 A SE 0102385A SE 0102385 A SE0102385 A SE 0102385A SE 0102385 D0 SE0102385 D0 SE 0102385D0
Authority
SE
Sweden
Prior art keywords
screening methods
methods
agents
dgkdelta
prophylaxis
Prior art date
Application number
SE0102385A
Other languages
English (en)
Inventor
Cecile Martijn
Eva Rupp-Thuresson
Harriet Wallberg-Henriksson
Juleen R Zierath
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE0102385A priority Critical patent/SE0102385D0/sv
Publication of SE0102385D0 publication Critical patent/SE0102385D0/sv
Priority to US10/188,648 priority patent/US20030036082A1/en
Priority to PCT/SE2002/001321 priority patent/WO2003004695A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/48Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase
    • C12Q1/485Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving transferase involving kinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90Enzymes; Proenzymes
    • G01N2333/91Transferases (2.)
    • G01N2333/912Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • G01N2333/91205Phosphotransferases in general
    • G01N2333/9121Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases
    • G01N2333/91215Phosphotransferases in general with an alcohol group as acceptor (2.7.1), e.g. general tyrosine, serine or threonine kinases with a definite EC number (2.7.1.-)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE0102385A 2001-07-03 2001-07-03 Screening methods SE0102385D0 (sv)

Priority Applications (3)

Application Number Priority Date Filing Date Title
SE0102385A SE0102385D0 (sv) 2001-07-03 2001-07-03 Screening methods
US10/188,648 US20030036082A1 (en) 2001-07-03 2002-07-02 Screening methods
PCT/SE2002/001321 WO2003004695A1 (en) 2001-07-03 2002-07-03 Methods for identifying agents that modulate diacylglycerol kinase delta (dgk&) alktivity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102385A SE0102385D0 (sv) 2001-07-03 2001-07-03 Screening methods

Publications (1)

Publication Number Publication Date
SE0102385D0 true SE0102385D0 (sv) 2001-07-03

Family

ID=20284727

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0102385A SE0102385D0 (sv) 2001-07-03 2001-07-03 Screening methods

Country Status (2)

Country Link
US (1) US20030036082A1 (sv)
SE (1) SE0102385D0 (sv)

Also Published As

Publication number Publication date
US20030036082A1 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
DK1112275T3 (da) Hidtil ukendte heteroaromatiske inhibitorer for fructose-1,6-bisphosphatase
GB0209891D0 (en) Novel compounds
BR0109062A (pt) Inibidores de frutose-1,6-bisfosfatase de arila
NO20044534L (no) Substituerte fenylacetamider og deres anvendelse som glukokinaseaktivatorer
IL140336A0 (en) Prodrug amino acid derivatives which inhibit dipeptidyl peptidase iv
NO20052159L (no) Substituert (tiazol-2-yl)-amid eller sulfonamid som glykokinase-aktivatorer nyttige ved behandling av type 2 diabetes.
BR0208741A (pt) Derivados de piperidina
MX2007006397A (es) Derivados de tetrahidropirano.
NO20051030L (no) Funksjonelle kardiomyocytter fra humane embryonale stamceller
MXPA02006826A (es) Un inhibidor de division celular y un metodo de produccion del mismo.
IL152891A0 (en) Methods for decreasing cell proliferation based on (3r, 4r)-8-delta tetrahydrocannabinol-11-oic acids
BRPI0409655A (pt) compostos heterocìclicos de ligação ao receptor para quimiocina com maior eficiência
WO2003106450A8 (de) Phenylaminopyrimidine und ihre verwendung als rho-kinase inhibitoren
MX2007011381A (es) Composicion de espirulinas rica en principios activos, su proceso de obtencion y su utilizacion.
SE0102385D0 (sv) Screening methods
DE60011677D1 (en) Tryptase-inhibitoren
EA200400751A1 (ru) Применение дезоксипеганина для лечения клинической депрессии
DK1244614T3 (da) Tryptase-inhibitorer
MY140194A (en) Novel fusidic acid derivatives
DE60334533D1 (de) Gewebe-engineering
SE0202608D0 (sv) New sequences
DK1366033T3 (da) Kemiske forbindelser
GB0128071D0 (en) Medicament
NO20040471L (no) 5,6,6a,1 1b-tetrahydro-7-oksa-5-azabenzo[c]fluoren-6-karboksylsyrederivater som NMDA-antagonister
SE0400522D0 (sv) A medical solution, a method for producing said medical solution and use thereof